CLINICAL_TRIALS
trial_result
· 2022-11-07
Clinical Trial Update: Ketamine to Treat Patients With Post-comatose Disorders of Consciousness [Phase 2, Phase 3]
Summary
A clinical trial update indicates ketamine is being studied in Phase 2 and Phase 3 for treating patients with post-comatose disorders of consciousness, currentl…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: University of Liege | Conditions: Disorder of Consciousness | Phase 2, Phase 3 | Status: RECRUITING